A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax

Bruce Russell, Rossarin Suwanarusk, Céline Borlon, Fabio T M Costa, Cindy S Chu, Marcus J Rijken, Kanlaya Sriprawat, Lucile Warter, Esther G L Koh, Benoit Malleret, Yves Colin, Olivier Bertrand, John H Adams, Umberto D'Alessandro, Georges Snounou, Francois Nosten, Laurent Rénia

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Currently, there are no reliable RBC invasion assays to guide the discovery of vaccines against Plasmodium vivax, the most prevalent malaria parasite in Asia and South America. Here we describe a protocol for an ex vivo P vivax invasion assay that can be easily deployed in laboratories located in endemic countries. The assay is based on mixing enriched cord blood reticulocytes with matured, trypsin-treated P vivax schizonts concentrated from clinical isolates. The reliability of this assay was demonstrated using a large panel of P vivax isolates freshly collected from patients in Thailand.

Original languageEnglish
Pages (from-to)e74-81
JournalBlood
Volume118
Issue number13
DOIs
Publication statusPublished - 29 Sept 2011

Keywords

  • Cells, Cultured
  • Hematologic Tests
  • High-Throughput Screening Assays
  • Host-Pathogen Interactions
  • Humans
  • Malaria, Vivax
  • Plasmodium vivax
  • Reproducibility of Results
  • Reticulocytes
  • Evaluation Studies
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Validation Studies

Fingerprint

Dive into the research topics of 'A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax'. Together they form a unique fingerprint.

Cite this